Digoxin and Alkeran drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Alkeran (melphalan). Common drug interactions include mitral valve incompetence among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Alkeran. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Alkeran?

Alkeran has active ingredients of melphalan. eHealthMe is studying from 5,429 Alkeran users. Check the latest studies of Alkeran.

On Jul, 12, 2026

21 people who take Digoxin and Alkeran together, and have interactions are studied.

What are the common drug interactions of Digoxin and Alkeran, by gender? *:

female:

Mitral valve incompetence (inefficient heart valve)
Mitral valve prolapse (heart's mitral valve doesn't work well)
Monoclonal gammopathy
Multiple injuries
Multiple myeloma (cancer of the plasma cells)
Muscle spasms (muscle contraction)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Nervousness

male:

Anaemia (lack of blood)
Cystitis haemorrhagic (blood in the urine and painful voiding)
Haemolytic anaemia (anaemia due to haemolysis)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Plasma cell myeloma (cancer that begins in plasma cells)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
C-reactive protein increased
Cellulitis (infection under the skin)
Constipation
Disease progression

What are the common drug interactions of Digoxin and Alkeran, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Anaemia (lack of blood)
Constipation
Death
Fatigue (feeling of tiredness)
Haemoglobin decreased
Platelet count decreased
Pyrexia (fever)
Ventricular fibrillation (abnormally irregular heart rhythm)
Abasia (inability to walk)
Abdominal pain

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 61.90%
Arrhythmias (irregular heartbeat): 5 people, 23.81%
Stable Angina (a constant chest pain): 3 people, 14.29%
Pain: 3 people, 14.29%
Lumbar Vertebral Fracture: 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Gastritis (inflammation of stomach): 3 people, 14.29%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 9.52%
Stress And Anxiety: 2 people, 9.52%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Alkeran?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously